TREATMENTS OF PROSTATE CANCER WITH COMBINATIONS OF ABIRATERONE ACETATE AND NIRAPARIB

The present disclosure relates to a combination of abiraterone acetate and niraparib, free-dose and fixed-dose combinations of abiraterone acetate and niraparib, and methods of treatment of prostate cancer with said combinations. La présente invention concerne une association d'acétate d'a...

Full description

Saved in:
Bibliographic Details
Main Authors TAMBWEKAR, KAUSTUBH RAMESH, DELAET, URBAIN ALFONS C, BERTELS, JOHNY, LOPEZ-GITLITZ, ANGELA, HEYNS, PHILIP ERNA H, LUYTEN, KATRIEN, QUINTEN, THOMAS RONALD A, HARTMAN KOK, PAUL J. A, MARCOZZI, TATIANA
Format Patent
LanguageEnglish
French
Published 11.11.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to a combination of abiraterone acetate and niraparib, free-dose and fixed-dose combinations of abiraterone acetate and niraparib, and methods of treatment of prostate cancer with said combinations. La présente invention concerne une association d'acétate d'abiratérone et de niraparib, des associations à dose libre et à dose fixe d'acétate d'abiratérone et de niraparib, et des méthodes de traitement du cancer de la prostate faisant appel auxdites associations.
Bibliography:Application Number: CA20213177137